Literature DB >> 1860633

Acute abdomen as the first presentation of pseudomembranous colitis.

G Triadafilopoulos1, A E Hallstone.   

Abstract

Acute abdomen was the presenting manifestation of pseudomembranous colitis in six men who had previously been treated with antibiotics and presented with abdominal distention, pain, fever, and leukocytosis with absent or mild diarrhea. Plain abdominal radiographs revealed megacolon in two, combined small and large bowel dilation in three, with one of them showing volvuluslike pattern, and isolated small bowel ileus in one. Emergency colonoscopy was performed successfully in all patients and revealed pseudomembranes in five and nonspecific colitis in one. All patients had positive latex test results for Clostridium difficile, and two tested positive for cytotoxicity. All patients were treated with IV metronidazole, resulting in resolution of symptoms and abdominal findings. In addition, two patients underwent colonoscopic decompression with improvement. Endoscopically, complete resolution of the pseudomembranes occurred at 4 weeks in all cases. No patient had a recurrence. It is concluded that (a) pseudomembranous colitis may present as abdominal distention mimicking small bowel ileus. Ogilvie's syndrome, volvulus, or ischemia; (b) in such cases, emergency colonoscopy is safe and useful for diagnosis and therapeutic decompression and may obviate the need for surgery; and (c) treatment with IV metronidazole is effective. Colitis due to C. difficile should be considered in the differential diagnosis of acute abdomen in patients previously treated with antibiotics.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1860633     DOI: 10.1016/0016-5085(91)90526-q

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  16 in total

Review 1.  Review of medical and surgical management of Clostridium difficile infection.

Authors:  B Faris; A Blackmore; N Haboubi
Journal:  Tech Coloproctol       Date:  2010-05-08       Impact factor: 3.781

2.  Pseudomembranous Colitis Caused by C. difficile.

Authors: 
Journal:  Curr Treat Options Gastroenterol       Date:  2000-06

3.  Comparison of four laboratory tests for diagnosis of Clostridium difficile-associated diarrhea.

Authors:  J Jacobs; B Rudensky; J Dresner; A Berman; M Sonnenblick; Y van Dijk; A M Yinnon
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-07       Impact factor: 3.267

Review 4.  Clostridium difficile-associated colitis.

Authors:  Mark W Hull; Paul L Beck
Journal:  Can Fam Physician       Date:  2004-11       Impact factor: 3.275

5.  The impact of Clostridium difficile on a surgical service: a prospective study of 374 patients.

Authors:  K C Kent; M S Rubin; L Wroblewski; P A Hanff; W Silen
Journal:  Ann Surg       Date:  1998-02       Impact factor: 12.969

Review 6.  Clostridium difficile infection in the intensive care unit.

Authors:  David J Riddle; Erik R Dubberke
Journal:  Infect Dis Clin North Am       Date:  2009-09       Impact factor: 5.982

7.  Pseudomembranous colitis presenting as acute colonic obstruction without diarrhea in a patient with gastric Burkitt lymphoma.

Authors:  Kenichi Nomura; Kohei Fukumoto; Daisuke Shimizu; Takashi Okuda; Naohisa Yoshida; Yuri Kamitsuji; Yosuke Matsumoto; Hideyuki Konishi; Yuji Ueda; Shigeo Horiike; Takeshi Okanoue; Masafumi Taniwaki
Journal:  World J Gastroenterol       Date:  2005-05-07       Impact factor: 5.742

Review 8.  Clostridium difficile-associated diarrhea in adults.

Authors:  Susan M Poutanen; Andrew E Simor
Journal:  CMAJ       Date:  2004-07-06       Impact factor: 8.262

Review 9.  Clostridium difficile associated infection, diarrhea and colitis.

Authors:  Perry Hookman; Jamie S Barkin
Journal:  World J Gastroenterol       Date:  2009-04-07       Impact factor: 5.742

10.  Prolonged ileus as a sole manifestation of pseudomembranous enterocolitis.

Authors:  Eran Elinav; David Planer; Moshe E Gatt
Journal:  Int J Colorectal Dis       Date:  2003-11-15       Impact factor: 2.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.